Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA embraces the first US application for a gene therapy, offering an accelerated test case
FDA embraces the first US application for a gene therapy, offering an accelerated test case
FDA embraces the first US application for a gene therapy, offering an accelerated test case
Submitted by
admin
on July 17, 2017 - 9:59am
Source:
Endpoints
News Tags:
FDA
gene therapy
Spark Therapeutics
Luxturna
RPE65-mediated inherited retinal disease
Headline:
FDA embraces the first US application for a gene therapy, offering an accelerated test case
Do Not Allow Advertisers to Use My Personal information
